Rituximab may not lead to increased infection rates in transplant recipients

Am J Transplant. 2010 Dec;10(12):2723-4. doi: 10.1111/j.1600-6143.2010.03195.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Infections / etiology*
  • Kidney Transplantation / adverse effects*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab